Docket Entries Since Last Update
NOTE: This court's RSS feed does not list MOTION entries, so Bloomberg Law cannot detect them and thus they will not be listed here. However, motions will be included if you update the docket.
Court Dockets
U.S. District Court
District of Delaware (Wilmington)
CIVIL DOCKET FOR CASE #: 1:22-cv-00637-CFC
District of Delaware (Wilmington)
CIVIL DOCKET FOR CASE #: 1:22-cv-00637-CFC
Aragon Pharmaceuticals, Inc. et al v. Lupin Limited et al
DOCKET INFORMATION
Minimize
| ||
| ||
| ||
| ||
| ||
| ||
| ||
|
| ||
|
| ||
|
Expand All
| Plaintiff |
Aragon Pharmaceuticals, Inc.
Plaintiff
|
| |
| Representation | |||
| Jack B. Blumenfeld Morris, Nichols, Arsht & Tunnell LLP 1201 North Market Street P.O. Box 1347 Wilmington, DE 19899 (302) 658-9200 Jbbefiling@mnat.com LEAD ATTORNEY ATTORNEY TO BE NOTICED | Jeremy A. Tigan Morris, Nichols, Arsht & Tunnell LLP 1201 North Market Street P.O. Box 1347 Wilmington, DE 19899 (302) 351-9106 JTigan@morrisnichols.com ATTORNEY TO BE NOTICED | ||
| Plaintiff |
Janssen Biotech, Inc.
Plaintiff
|
| |
| Representation | |||
| Jack B. Blumenfeld (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED | Jeremy A. Tigan (See above for address) ATTORNEY TO BE NOTICED | ||
| Defendant |
Lupin Limited
Defendant
|
| |
| Representation | |||
| John C. Phillips , Jr. Phillips, McLaughlin & Hall, P.A. 1200 N. Broom St Wilmington, DE 19806 (302) 655-4200 jcp@pmhdelaw.com LEAD ATTORNEY ATTORNEY TO BE NOTICED | |||
| Defendant |
Lupin Pharmaceuticals, Inc.
Defendant
|
| |
| Representation | |||
| John C. Phillips , Jr. (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED | |||
Numbers shown are court assigned numbers.
| Entry | Filed | Description | |
|---|---|---|---|
| 1 | May 13, 2022 | View | COMPLAINT filed against Lupin Limited, Lupin Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-3873367.) - filed by Janssen Biotech, Inc., Aragon Pharmaceuticals, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(apk) (Entered: 05/13/2022) |
| 2 | May 13, 2022 | Request | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 05/13/2022) |
| 3 | May 13, 2022 | Request | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/4/2022. Date of Expiration of Patent: 6/4/2033.Thirty Month Stay Deadline: 8/14/2025. (apk) (Entered: 05/13/2022) |
| 4 | May 13, 2022 | Request | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,481,663 B2. (apk) (Entered: 05/13/2022) |
| 5 | May 13, 2022 | Request | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc. filed by Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., Sloan Kettering Institute for Cancer Research. (apk) (Entered: 05/13/2022) |
| 6 | May 13, 2022 | Request | Summons Issued as to Lupin Limited on 5/13/2022; Lupin Pharmaceuticals, Inc. on 5/13/2022. (Attachments: # 1 Summons Issued)(apk) (Entered: 05/13/2022) |
| 7 | May 16, 2022 | Request | SUMMONS Returned Executed by Janssen Biotech, Inc., Aragon Pharmaceuticals, Inc., Sloan Kettering Institute for Cancer Research. Lupin Pharmaceuticals, Inc. served on 5/16/2022, answer due 6/6/2022. (Blumenfeld, Jack) (Entered: 05/16/2022) |
| 8 | May 17, 2022 | Request | AFFIDAVIT of Service for Summons, Complaint and related papers served on Lupin Limited on May 17, 2022, filed by Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., Sloan Kettering Institute for Cancer Research. (Tigan, Jeremy) (Entered: 05/17/2022) |
| May 18, 2022 | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nms) (Entered: 05/18/2022) | ||
| 9 | Jun 3, 2022 | Request | STIPULATION TO EXTEND TIME for Defendants to answer, move or otherwise respond to the Complaint (D.I. 1) to August 15, 2022 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Phillips, John) (Entered: 06/03/2022) |
| Jun 3, 2022 | SO ORDERED, re 9 STIPULATION TO EXTEND TIME for Defendants to answer, move or otherwise respond to the Complaint (D.I. 1) to August 15, 2022, filed by Lupin Limited, Lupin Pharmaceuticals, Inc. Reset Answer Deadlines: Lupin Limited answer due 8/15/2022; Lupin Pharmaceuticals, Inc. answer due 8/15/2022. Ordered by Judge Colm F. Connolly on 6/3/2022. (kmd) (Entered: 06/03/2022) |